Selected Financial Data
since 2012
Income Statement
AbbVie Inc., selected items from income statement, long-term trends
US$ in millions
| 12 months ended: | Net revenues | Operating earnings | Net earnings attributable to AbbVie Inc. |
|---|---|---|---|
| Dec 31, 2023 | 54,318) | 12,757) | 4,863) |
| Dec 31, 2022 | 58,054) | 18,117) | 11,836) |
| Dec 31, 2021 | 56,197) | 17,924) | 11,542) |
| Dec 31, 2020 | 45,804) | 11,363) | 4,616) |
| Dec 31, 2019 | 33,266) | 12,983) | 7,882) |
| Dec 31, 2018 | 32,753) | 6,383) | 5,687) |
| Dec 31, 2017 | 28,216) | 9,592) | 5,309) |
| Dec 31, 2016 | 25,638) | 9,384) | 5,953) |
| Dec 31, 2015 | 22,859) | 7,537) | 5,144) |
| Dec 31, 2014 | 19,960) | 3,411) | 1,774) |
| Dec 31, 2013 | 18,790) | 5,664) | 4,128) |
| Dec 31, 2012 | 18,380) | 5,817) | 5,275) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).
Balance Sheet: Assets
AbbVie Inc., selected items from assets, long-term trends
US$ in millions
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2023 | 33,002) | 134,711) |
| Dec 31, 2022 | 28,463) | 138,805) |
| Dec 31, 2021 | 27,928) | 146,529) |
| Dec 31, 2020 | 24,173) | 150,565) |
| Dec 31, 2019 | 49,519) | 89,115) |
| Dec 31, 2018 | 16,945) | 59,352) |
| Dec 31, 2017 | 21,223) | 70,786) |
| Dec 31, 2016 | 16,187) | 66,099) |
| Dec 31, 2015 | 16,314) | 53,050) |
| Dec 31, 2014 | 16,088) | 27,547) |
| Dec 31, 2013 | 17,848) | 29,198) |
| Dec 31, 2012 | 15,354) | 27,008) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).
Balance Sheet: Liabilities and Stockholders’ Equity
AbbVie Inc., selected items from liabilities and stockholders’ equity, long-term trends
US$ in millions
| Current liabilities | Total debt and finance lease obligations | Stockholders’ equity (deficit) | |
|---|---|---|---|
| Dec 31, 2023 | 37,841) | 59,385) | 10,360) |
| Dec 31, 2022 | 29,538) | 63,271) | 17,254) |
| Dec 31, 2021 | 35,194) | 76,684) | 15,408) |
| Dec 31, 2020 | 28,661) | 86,056) | 13,076) |
| Dec 31, 2019 | 15,585) | 66,728) | (8,172) |
| Dec 31, 2018 | 17,239) | 40,310) | (8,446) |
| Dec 31, 2017 | 16,641) | 37,368) | 5,097) |
| Dec 31, 2016 | 9,781) | 36,842) | 4,636) |
| Dec 31, 2015 | 10,894) | 31,671) | 3,945) |
| Dec 31, 2014 | 11,400) | 15,011) | 1,742) |
| Dec 31, 2013 | 6,879) | 14,723) | 4,492) |
| Dec 31, 2012 | 6,776) | 15,672) | 3,363) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).
Cash Flow Statement
AbbVie Inc., selected items from cash flow statement, long-term trends
US$ in millions
| 12 months ended: | Cash flows from operating activities | Cash flows from investing activities | Cash flows from financing activities |
|---|---|---|---|
| Dec 31, 2023 | 22,839) | (2,009) | (17,222) |
| Dec 31, 2022 | 24,943) | (623) | (24,803) |
| Dec 31, 2021 | 22,777) | (2,344) | (19,039) |
| Dec 31, 2020 | 17,588) | (37,557) | (11,501) |
| Dec 31, 2019 | 13,324) | 596) | 18,708) |
| Dec 31, 2018 | 13,427) | (1,006) | (14,396) |
| Dec 31, 2017 | 9,960) | (274) | (5,512) |
| Dec 31, 2016 | 7,041) | (6,074) | (3,928) |
| Dec 31, 2015 | 7,535) | (12,936) | 5,752) |
| Dec 31, 2014 | 3,549) | (926) | (3,293) |
| Dec 31, 2013 | 6,267) | 879) | (3,442) |
| Dec 31, 2012 | 6,345) | (2,418) | 1,931) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).
Per Share Data
AbbVie Inc., selected data per share, long-term trends
US$
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Dec 31, 2023 | 2.73 | 2.72 | 5.99 |
| Dec 31, 2022 | 6.65 | 6.63 | 5.71 |
| Dec 31, 2021 | 6.48 | 6.45 | 5.31 |
| Dec 31, 2020 | 2.73 | 2.72 | 4.84 |
| Dec 31, 2019 | 5.30 | 5.28 | 4.39 |
| Dec 31, 2018 | 3.67 | 3.66 | 3.95 |
| Dec 31, 2017 | 3.31 | 3.30 | 2.63 |
| Dec 31, 2016 | 3.65 | 3.63 | 2.35 |
| Dec 31, 2015 | 3.15 | 3.13 | 2.10 |
| Dec 31, 2014 | 1.11 | 1.10 | 1.75 |
| Dec 31, 2013 | 2.58 | 2.56 | 2.00 |
| Dec 31, 2012 | 3.35 | 3.35 | 0.00 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.